Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases

This study aimed to investigate the use of Plasma Rich in Growth Factors (PRGF) associated with tissue ReGeneraTing Agent (RGTA) drops for the treatment of noninfectious corneal ulcers. RGTA treatment was applied (one drop every two days); however, if ulcer closure was not achieved, PRGF eye drops t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez-Ávila, Ronald M., Uribe-Badillo, Edmar, Fernández-Vega González, Carlos, Muruzabal, Francisco, de la Sen-Corcuera, Borja, Baamonde, Begoña, Quirós, Luis M., Anitua, Eduardo, Merayo-Lloves, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293442/
https://www.ncbi.nlm.nih.gov/pubmed/34287367
http://dx.doi.org/10.3390/vision5030034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293442/
https://www.ncbi.nlm.nih.gov/pubmed/34287367
http://dx.doi.org/10.3390/vision5030034

Ejemplares similares